Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Immuno-Oncology Firm to Collaborate on Third Clinical Trial with Genentech

Descriptions of the new study and upcoming data readouts for this California-based firm were provided in an H.C. Wainwright & Co. report. In an April 29 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Forty Seven Inc. (FTSV...
Streetwise Reports | May 2, 2019 |

Revolutionizing immunotherapies with groundbreaking DPX platform

The following is a transcription of the above video, and The Market Online has edited it for clarity . BioVaxys Technology Corp (CSE:BIOV) is a Canadian-based clinical stage biopharmaceutical company focused on improving patient lives with novel immunotherapies. CE...
Lyndsay Malchuk | July 30, 2024 |

These Technology Stocks Could Thrive in the New COVID-19 Work-from-Home Economy

Just last month, North American financial markets were chugging along, setting multiple all-time highs in February. A lot has changed in the past 30 days due to the rapid rise and global spread of the novel coronavirus (COVID-19) . The way of life we once knew has change...
Streetwise Reports | March 27, 2020 |

Buzz on the Bullboards: The Return of Crypto?

2021 has started off with a bang for investors, as many sectors continue to weather the storm under COVID-19, which continues to spread to record numbers in the US, while the country watches as its outgoing President Donald Trump is impeached for a second time. Des...
Stockhouse Editorial | January 13, 2021 |

Immuno-oncology Firm to Co-Develop Companion Diagnostic for Cervical Dysplasia

The partnership news and upcoming data readouts are reviewed in an H.C. Wainwright & Co. report. In a May 17 report, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals Inc. (INO:NASDAQ) will collaborate with QIAGEN, a molecula...
Streetwise Reports | May 27, 2019 |

MOU to Process Glencore's Feedstock 'Positive Step' for Cobalt Firm's Refinery

The terms and implications of the arrangement are reviewed in a Canaccord Genuity report. In a May 21 research note, Canaccord Genuity analyst Eric Zaunscherb reported that First Cobalt Corp. (FCC:TSX.V; FTSSF:OTCQX; FCC:ASX) signed a memorandum of underst...
Streetwise Reports | May 27, 2019 |

Buzz on the Bullboards: Top Stocks Plan Moves for 2022

( Ore stockpiles at the Kakula North decline containing 2.04 million tonnes grading 5.13% copper as of December 31, 2021. Image via Ivanhoe Mines Ltd.) 2022 started off with a bang for investors as many sectors were rocked by the spread of the Omicron Coronavir...
Stockhouse Editorial | January 18, 2022 |

Buzz on the Bullboards: Who is shining through the market slump?

The market story this week has been less impressive on both sides of the border than what we saw in the week where February turned to March. Recent losses and flatline trading have negated Wall Street’s previous record-setting run where major U.S. indices ...
Jonathon Brown | March 7, 2024 |

First Cobalt Corp. & Glencore Sign MOU on First Cobalt’s Cobalt Refinery

This is big, really big. I can’t say that it’s a surprise that Glencore might want to partner with First Cobalt Corp . (TSX-V: FCC) / (QTCQX: FTSSF), but it would be by far the best possible outcome for management’s strategi...
Peter Epstein | May 22, 2019 |

Biopharma's New License Agreement with Gilead 'Brings Strong Validation and Economics'

The specifics and benefits of the deal are discussed in an H.C. Wainwright & Co. report. In a July 22 research note, H.C. Wainwright & Co. analyst Ed Arce reported that DURECT Corp. (DRRX:NASDAQ) entered an agreement concerning its SABER technology and SAB...
Streetwise Reports | July 24, 2019 |
1 2